MWM
ABBV icon

Maltin Wealth Management’s AbbVie ABBV Stock Holding History

Maltin Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
1,449
+1
+0.1% +$215 0.12% 103
2026
Q1 		$315K Buy
1,448
+4
+0.3% +$887 0.12% 104
2025
Q4 		$330K Sell
1,444
-2
-0.1% -$456 0.13% 99
2025
Q3 		$335K Buy
1,446
+5
+0.3% +$1.02K 0.14% 98
2025
Q2 		$267K Buy
1,441
+5
+0.3% +$929 0.12% 104
2025
Q1 		$301K Sell
1,436
-13
-0.9% -$2.53K 0.14% 102
2024
Q4 		$257K Sell
1,449
-74
-5% -$13.6K 0.13% 111
2024
Q3 		$301K Buy
1,523
+6
+0.4% +$1.12K 0.15% 97
2024
Q2 		$260K Sell
1,517
-80
-5% -$13.3K 0.14% 102
2024
Q1 		$291K Buy
1,597
+6
+0.4% +$1.03K 0.16% 95
2023
Q4 		$247K Buy
1,591
+8
+0.5% +$1.17K 0.16% 98
2023
Q3 		$236K Sell
1,583
-606
-28% -$89K 0.16% 101
2023
Q2 		$295K Sell
2,189
-835
-28% -$122K 0.21% 84
2023
Q1 		$482K Buy
3,024
+21
+0.7% +$3.21K 0.35% 67
2022
Q4 		$485K Sell
3,003
-322
-10% -$49.4K 0.35% 67
2022
Q3 		$446K Buy
3,325
+23
+0.7% +$3.3K 0.35% 77
2022
Q2 		$506K Sell
3,302
-42
-1% -$6.42K 0.37% 76
2022
Q1 		$542K Sell
3,344
-2,899
-46% -$421K 0.36% 75
2021
Q4 		$845K Buy
6,243
+52
+0.8% +$6.14K 0.51% 59
2021
Q3 		$668K Buy
+6,191
New +$707K 0.41% 60
2020
Q3 		– Sell
-2,098
Closed -$206K – 87
2020
Q2 		$206K Buy
+2,098
New +$185K 0.16% 80

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Maltin Wealth Management's ABBV Position: Q2 2026 in Review

Maltin Wealth Management increased its AbbVie (ABBV) stake by 0.07% in Q2 2026, buying an estimated $215 and bringing the position to 1,449 shares worth $365K. The position accounts for 0.12% of the portfolio, ranked #103.

Maltin Wealth Management first reported a position in ABBV in Q2 2020 and has held it in 21 quarters since. The position peaked at $845K in Q4 2021. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Maltin Wealth Management held 1,449 shares of AbbVie worth $365K as of Q2 2026.
  • Maltin Wealth Management bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.12% of Maltin Wealth Management's portfolio in Q2 2026, its #103 holding.
  • Maltin Wealth Management first reported a position in AbbVie in Q2 2020 and has held it in 21 quarters since.
  • Maltin Wealth Management's AbbVie position peaked at $845K in Q4 2021.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Maltin Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.